Importantly, Ulk1 deficiency remodeled the tumor immune microenvironment by reducing tumor-promoting polymorphonuclear myeloid-derived suppressor cells and neutrophils while substantially enhancing recruitment of cytotoxic CD8+ T cells and major histocompatibility complex II+ antigen-presenting cells. This evidence concerns the gene CD8A and neoplasm.